Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 26 February 1993
Length: 20 pages
Data source: Published sources
Notes: Customers will need to be registered on the Harvard Business Publishing website in order to view the video.
http://cb.hbsp.harvard.edu/cb/search/9-792-004?Ntk=HEMainSearch&N=0
Abstract
This case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details. Burroughs Wellcome Co, developer of AZT, the first drug approved by the US Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the US government. In spite of repeated demands over the previous two years to lower the price of AZT (trademarked Retrovie), Burroughs Wellcome and its parent company, London-based Wellcome PLC, have refused, claiming that the $6,300 annual (wholesale) cost of the drug per person is justified, based on high research, development, production, and other costs associated with the drug. The firm's opponents accuse it of using an existing chemical compound, ample government research assistance, and a co-operative regulatory system to gain a monopoly on the only approved treatment available for people with AIDS. The case gives students the opportunity to explore the economics and regulation of the pharmaceutical industry, wrestle with the ethics of drug pricing, and analyze the formulation of public relations strategies on the part of both private companies and activist groups in the age of AIDS.
Location:
Industry:
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Length: 29 pages
Spanish language
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 26 February 1993
Revision date: 7-May-2019
Length: 22 pages
Data source: Published sources
Notes: Customers will need to be registered on the Harvard Business Publishing website in order to view the video.
http://cb.hbsp.harvard.edu/cb/search/9-792-004?Ntk=HEMainSearch&N=0
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 2 March 1993
Length: 2 pages
Data source: Published sources
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 2 March 1993
Length: 4 pages
Data source: Published sources
About
Abstract
This case is accompanied by a Video Short that can be shown in class or included in a digital coursepack. Instructors should consider the timing of making the video available to students, as it may reveal key case details. Burroughs Wellcome Co, developer of AZT, the first drug approved by the US Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the US government. In spite of repeated demands over the previous two years to lower the price of AZT (trademarked Retrovie), Burroughs Wellcome and its parent company, London-based Wellcome PLC, have refused, claiming that the $6,300 annual (wholesale) cost of the drug per person is justified, based on high research, development, production, and other costs associated with the drug. The firm's opponents accuse it of using an existing chemical compound, ample government research assistance, and a co-operative regulatory system to gain a monopoly on the only approved treatment available for people with AIDS. The case gives students the opportunity to explore the economics and regulation of the pharmaceutical industry, wrestle with the ethics of drug pricing, and analyze the formulation of public relations strategies on the part of both private companies and activist groups in the age of AIDS.
Settings
Location:
Industry:
Related
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Length: 29 pages
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 26 February 1993
Revision date: 7-May-2019
Length: 22 pages
Data source: Published sources
Notes: Customers will need to be registered on the Harvard Business Publishing website in order to view the video.
http://cb.hbsp.harvard.edu/cb/search/9-792-004?Ntk=HEMainSearch&N=0
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 2 March 1993
Length: 2 pages
Data source: Published sources
Subject category:
Economics, Politics and Business Environment
Published by:
Harvard Business Publishing
Version: 2 March 1993
Length: 4 pages
Data source: Published sources